| |
The Quality Factor in Hemostasis Testing
The Hemostasis Reference Laboratory (HRL) is a Canadian Laboratory that is accredited by the College of American Pathologists (CAP) and works to the International Standard of ISO 15189: Medical laboratories -- Particular requirements for quality and competence.
We are located in the Henderson Research Centre in Hamilton, Ontario, a centre of excellence for the diagnosis and treatment of thrombosis.
We offer pharmaceutical companies, diagnostic manufacturers, and researchers a complete range of testing for clinical trials, research projects and product evaluation. |
|
 |
Our expertise is in the measurement of routine and esoteric coagulation, fibrinolytic, cytokine testing and DNA analysis.
If you require another test parameter, we have the facilities to develop and validate new assays.
Our Mission Statement
We are focused on our customers and highly responsive to their needs. We will maintain our flexibility and strive to improve our fast-response capabilities to capture new opportunities. We highly value and will maintain our reputation for quality service and support, dependability, ethical conduct and fairness in pricing.
We will actively explore ways in which to expand our client base while maintaining our
excellence in service to existing clients.
Our key asset is our talented and dedicated people. We will continue to treat each other and others
with respect and to encourage and create the opportunities for personal growth and professional
development. We will constantly strive to identify and implement innovation and improvements in
processes, systems, and the work environment. We will continue to encourage employee feedback
and input in discussing and developing new ideas and areas for development.
Our location in Henderson Research Centre, Hamilton
|
|
 |
NOW AVAILABLE!!
Microparticle Activity Analysis
For more information see our News and Upcoming Events page.
Genotyping for Warfarin Therapy Cytochrome
P450 2C9 gene (CYP2C9) & Vitamin K Epoxide Reductase Complex 1 gene (VKORC1) genotyping is now available. For more information see our News and Upcoming Events page.
XXII Congress of the International
Society on Thrombosis and
Haemostasis
The XXII ISTH Congress is to be held in Boston from July 11 to 16, 2009. Marilyn Johnston has had two abstracts accepted for poster presentation and publication. For more information see our News and Upcoming Events page.
Molecular Cancer Therapeutics
Article
HRL is pleased to inform of a publication by
Lucy Shin, the recipient of the HRL Scholarship for 2006, titled "Effects of the chemotherapeutic agent doxorubicon on the protein C anticoagulant pathway". For more information see our News and Upcoming Events page.
PROCALCITONIN
Testing
The B·R·A·H·M·S PCT LIA assay has been cleared by the FDA for the early diagnosis of patients at risk for progression to severe sepsis.
HRL offers Procalcitonin (PCT) testing for research purposes. The clinical utility in select patient populations has already been identified and continued studies to discover the optimal utilization of this marker as it relates to patient management is foreseen. The availability of this FDA-cleared PCT
assay will encourage further international
clinical-scientific studies. Click here to view the News and Upcoming Events page. |
|
|
